{"disease":{"id":"serious-bacterial-infection","name":"serious bacterial infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07134751","title":"Febrile Infants Swedish Study","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT03580044","title":"Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Pfizer","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}